When the Diagnosis is Psoriasis, the Treatment is Clear. XTRAC.
XTRAC is the only FDA-cleared, clinically proven excimer laser that gets skin clear of psoriasis—and it works fast, with many patients seeing significant improvement and long-lasting remissions. Because XTRAC delivers a highly targeted, therapeutic beam of UVB light only to areas of the skin affected by psoriasis, healthy skin surrounding the lesions stays that way.
XTRAC clears the symptoms, prolongs the remission and returns skin to a clinically healthy state in record time. All of which means XTRAC delivers consistently predictable results so patients experience more good days of living than bad.
- Effective treatment—symptoms reduced generally in 10-12 treatment sessions
- Long-lasting relief—typically several months free of symptoms*
- Simple, painless treatment—sessions are very short
- Relief without messy creams and daily skin care regimen
- Covered by most major insurance companies, available by Rx
*Results may vary, talk to your doctor about the right treatment protocol for you.
Side Effects/Risks: XTRAC has none of the drawbacks often associated with other psoriasis treatments-such as premature aging of healthy skin, skin thinning, resistance to medication, or potential negative systemic side effects. Some patients, however, experience a reaction similar to sunburn or blistering at the site of the treated area and in some cases, an increase in pigmentation may occur.
VITILIGO is Not Forever. XTRAC for Even Skin.
XTRAC treatments can minimize and, in many cases, even eliminate vitligo depigmented patches. The XTRAC [308 nm] excimer laser delivers a targeted beam of UVB light and only the areas of skin affected by vitiligo receive the laser energy.
Though the laser spot size measures only 18mm x 18mm, due to rapid exposure times, relatively large, discrete areas can be treated in just five to 10 minutes, which is much quicker than the duration of conventional phototherapy light sessions. And most importantly, XTRAC treatments achieve complete response rates faster in a higher proportion of patients.